It seems like you are thinking about starting a business where you will be manufacturing generic versions of solid dose products. Are you thinking of contract manufacturing for others? Are you planning to develop your own generic products and manufacture them? And what are your intended markets? US, Europe, India, others?
If you are thinking about only contract manufacturing, the intended market is very important since the regulatory agency from that market must approve your facility, and this is a lengthy and complex process. But of course potentially very profitable one. You could certainly do this in India where costs would be lower. And you could do it in the where costs would be potentially higher but there are many other advantages. You could potentially purchase an existing approved plant in the US or in Puerto Rico. There are some avaialble and more come on the market often enough.
Regarding start up capital, it really depends on what you want to do. But I think to have and run a facility, to do business development, to gain FDA approval.....you probably need a minimum of $10-$20 million.
If you provide more information, perhaps I could sahre some more on this forum.
I think starting your company in India is the best way to go. After you can establish some branches in other countries. But if you live in the US, New Hampshire, and Texas are also great places to start a company. I started mine in Boston, but it is expensive.
I do not have any information about the equipment.
14th round of financial assistance for investment projects
SIEPA has announced a public call for another round of financial assistance for new investment projects in Serbia. Application deadline is September 9, 2011.
The funds may be used for financing investment projects in the manufacturing sector, the internationally marketable services sector and strategic projects in the field of tourism. The funds may not be used for financing investment projects in primary agriculture, the hospitality industry, retail, and the production of synthetic fibers and coal.
Apply now for financial support by the Government of Serbia offered for Greenfield and Brownfield projects in all industries, except for primary agriculture, the hospitality industry, retail, and the production of synthetic fibers and coal.
In addition to existing benefits, namely strategic geographic location, duty-free exports to the countries of Southeast Europe and Russia, the lowest corporate tax rate in Europe of 10% and an educated and experienced workforce available at the competitive cost, Serbia offers financial support to investors. So far SIEPA has published 13 calls in which 120 million euros was allocated for the creation of more than 28,000 jobs in Serbia. Based on the Decree of the Government of the Republic of Serbia, the investment projects in all sectors, except trade, catering and agriculture, are eligible to apply for grants. The funds are intended to finance investment projects in the manufacturing and service sectors which may be subject to international trade.
For standard-scale Greenfield and Brownfield projects in the manufacturing, export-related services sector and tourism, non-refundable state funds are offered in the range between €2,000 and €10,000 per new job created within three years.
For large investors, a special financial package is available. If a project's value exceeds €200 million, with the minimum of 1,000 new jobs created within 3 years, the state may cover 20% of the investment. Investments of over €50 million that create the minimum of 300 new jobs within 3 years, can be subsidized up to 20% of the project's value.
For more information please visit: http://www.siepa.gov.rs/site/en/home/1/investing_in_serbia/investme...
Are you local of NY metro area? If you are may be we can talk. I am also in the process of starting a contract manufacturing company. Respond to me and let me know if can get together to discuss.
I am wish to embark in the same direction but somalia, east africa, and intend to start up manufacturing plant and produce for local markets that are not FDA or EU markets.
our capital are small and ear-marked and limited, so any advice or links you have developed, please forward me their contacts to me as well.
thoroughly appreciate your insight, advice and views